AstraZeneca sells rights for Seroquel to Luye Pharma for $538 million

LONDON (Reuters) - British pharma company AstraZeneca said it had sold the rights for Seroquel, a treatment for schizophrenia and bipolar disease, to Luye Pharma Group for $538 million, as part of a strategy to focus on other therapy areas.

from Reuters: Health News https://ift.tt/2HWSvc5